Skip to main content
Livermore
Livermore
ZHEN

Rani Therapeutics Holdings, Inc.

RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001856725

In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of RANI: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders38264+28
Shares4.03M266.1K44.8M+41.1M (+1,089.6%)
Value$2.02M$133.0K$60.5M+$58.6M (+3,113.9%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to RANI in Q4 2025
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.8,500,000$11.5M0.12%
Samsara BioCapital, LLC8,500,000$11.5M1.18%
AWM Investment Company, Inc.6,500,000$8.78M0.85%
SymBiosis Capital Partners, LLC6,300,000$8.51M7.77%
Longaeva Partners L.P.2,113,435$2.85M0.34%
Siren, L.L.C.2,000,000$2.70M0.08%
683 Capital Management, LLC487,168$657.7K0.05%
Squarepoint Ops LLC344,378$464.9K0.00%
Goldman Sachs Group Inc285,832$385.9K0.00%
Millennium Management LLC163,300$220.5K0.00%
Qube Research & Technologies Ltd148,226$200.1K0.00%
Bridgeway Capital Management, LLC114,500$154.6K0.00%
Farallon Capital Management, L.L.C.78,000$105.3K0.00%
Omers Administration Corp69,200$93.4K0.00%
Susquehanna International Group, LLP56,822$76.7K0.00%
Citigroup Inc53,095$71.7K0.00%
Virtu Financial LLC51,178$69.0K0.00%
Lighthouse Investment Partners, LLC42,840$57.8K0.00%
Two Sigma Securities, LLC35,874$48.4K0.01%
Jefferies Financial Group Inc.29,870$40.3K0.00%
Unique Wealth Strategies, LLC24,600$33.2K0.01%
China Universal Asset Management Co., Ltd.15,894$21.5K0.00%
Bronte Capital Management Pty Ltd.14,868$20.1K0.00%
Balyasny Asset Management LLC14,655$19.8K0.00%
Farther Finance Advisors, LLC13,800$18.6K0.00%
Disciplined Investors, L.L.C.12,200$16.5K0.01%
Sanctuary Advisors, LLC12,014$16.2K0.00%
Ewa, LLC11,081$15.0K0.00%
Cary Street Partners Financial LLC10,550$14.2K0.00%
Barclays PLC8,096$10.9K0.00%
Mirae Asset Global Investments Co., Ltd.4,740$6.40K0.00%
State of Wyoming2,076$2.80K0.00%
GF Fund Management Co. Ltd.1,857$2.51K0.00%
BNP Paribas Arbitrage, SA1,616$2.18K0.00%
Jones Financial Companies LLLP1,000$1.35K0.00%
Elyxium Wealth, LLC760$1.03K0.00%
CWM, LLC175$00.00%

Sold out (9)

Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of RANI in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Citadel Advisors LLC452,542$226.2K
HRT Financial LP113,206$56.0K
Insigneo Advisory Services, LLC47,500$23.7K
XTX Topco Ltd44,077$22.0K
Brown Advisory Inc32,911$16.4K
Renaissance Technologies LLC24,908$12.4K
RSM US Wealth Management LLC11,813$5.90K
EverSource Wealth Advisors, LLC980$490
Simplex Trading, LLC819$0

Not filed for Q4 2025 yet (2)

Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RANI in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Takeda Pharmaceutical Co Ltd203,190$101.6K
Lasry Marc62,887$31.4K